Title,Abstract,Time Stamp
BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates,"MAINZ, Germany and NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Pfizer Inc. (NYSE: PFE), have announced today that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 1/2 clinical trial for BioNTech’s BNT162 vaccine program to prevent COVID-19 infection. BioNTech and Pfizer are jointly developing BNT162. The trial is the first clinical trial of a COVID-19 vaccine candidate to start in Germany, and is part of a global development program. Pfizer and BioNTech will also conduct trials for BNT162 in the United States upon regulatory approval, which is expected shortly.",2020-04-22
Pfizer Gets German Approval To Start COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works.,"When Pfizer (NYSE:PFE) announced on April 9 that its five-point plan included a promising coronavirus treatment and a potential vaccine candidate in the works, shares soared to their highest point since the beginning of March. Pfizer stock has been on an upward trajectory ever since. The company is hoping to start phase 1 trials for its prospective coronavirus treatment by the fall. Pfizer is working on its vaccine candidate with German drugmaker BioNTech, with the German regulatory authority approving their phase 1/2 clinical trial on April 22.",2020-04-23
Pfizer Rises on Nod to Start First In-Human COVID-19 Vaccine Trial in Germany,U.S. drugmaker Pfizer Inc. (PFE) and BioNTech SE (BNTX) got the green light from German regulators to conduct the first in-human clinical trial in Germany of a potential coronavirus vaccine.,2020-04-22
Pfizer and BioNTech announce joint development of a potential COVID-19 vaccine,"Pharma giant Pfizer announced on Tuesday that it’s working on a potential COVID-19 vaccine with BioNTech, a German company working on new kinds of immunotherapy treatments. The joint effort, confirmed Tuesday via a signed letter of intent, will see both partners work together on a messenger RNA-based vaccine that will seek to prevent people from contracting the new coronavirus.",2020-03-17
"Pfizer clinches coronavirus vaccine deal, sees potential in antiviral treatment",NEW YORK (Reuters) - U.S. drugmaker Pfizer Inc PFE.N said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients infected with the novel coronavirus.,2020-04-09
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany,"MAINZ, Germany and NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Pfizer Inc. (NYSE: PFE) have announced that the first cohort of BioNTech’s Phase 1/2 clinical trial has been dosed. Twelve study participants were dosed with vaccine candidate BNT162 in Germany since dosing began on April 23, 2020. The trial is the first clinical trial of a COVID-19 vaccine candidate in Germany. Pfizer and BioNTech plan to initiate trials for BNT162 in the United States upon regulatory approval, which is expected shortly.",2020-04-29
NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options,"The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration and the European Medicines Agency to develop an international strategy for a coordinated research response to the COVID-19 pandemic. The planned Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership will develop a collaborative framework for prioritizing vaccine and drug candidates, streamlining clinical trials, coordinating regulatory processes and/or leveraging assets among all partners to rapidly respond to the COVID-19 and future pandemics. This is part of the whole-of-government, whole-of-America response the Administration has led to beat COVID-19.",2020-04-17
BioNTech and Pfizer announce approval to start clinical trials of COVID-19 vaccine candidates,"MAINZ, Germany, and NEW YORK, USA, April 22, 2020 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Pfizer Inc. (NYSE: PFE), have announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 1/2 clinical trial for BioNTech’s BNT162 vaccine program to prevent COVID-19 infection. BioNTech and Pfizer are jointly developing BNT162. The trial is the first clinical trial of a COVID-19 vaccine candidate to start in Germany, and is part of a global development program. Pfizer and BioNTech will also conduct trials for BNT162 in the United States upon regulatory approval, which is expected shortly.",2020-04-28
Race for Coronavirus Vaccine Accelerates as Pfizer Says U.S. Testing to Begin Next Week,"The race for a vaccine to combat the new coronavirus is moving faster than researchers and drugmakers expected, with Pfizer Inc. PFE 1.00% joining several other groups saying that they had accelerated the timetable for testing and that a vaccine could be ready for emergency use in the fall.",2020-04-28
Pfizer and BioNTech preparing 'millions' of COVID mRNA vaccines,"Pfizer and BioNTech provide further details on their work against COVID-19, including clinical trial plans and scaling of manufacture. ",2020-04-14
Pfizer Announced a Plan to Identify a Possible Coronavirus Treatment,"Following a meeting on Monday at the White House, the pharmaceutical company  Pfizer   announced a program to screen antiviral drugs in its development pipeline to determine whether they could be effective against the new coronavirus.",2020-03-30
Pfizer weighs working with BioNTech on potential coronavirus vaccine: R&D head,"(Reuters) - Pfizer Inc is considering a collaboration with German drugmaker BioNTech SE to develop vaccines for the coronavirus using BioNTech’s mRNA-based drug development platform, Pfizer’s R&D head told Reuters on Thursday.",2020-03-05
FDA approves Pfizer’s Covid vaccine for emergency use as U.S. reaches pivotal moment in the pandemic,"The Food and Drug Administration has approved Pfizer and BioNTech’s coronavirus vaccine for emergency use, a monumental turning point in the once-in-a-century pandemic that has taken nearly 300,000 American lives in less than a year and wreaked havoc on the U.S. economy.",2020-12-11
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine,"Today, the U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S.",2020-12-11
Here's what we know about Pfizer's vaccine -- including who could get it first,"The director of the US Centers for Disease Control and Prevention on Sunday accepted the recommendation of the agency's vaccine advisory committee, clearing the way for Pfizer and BioNTech's vaccine to be administered in the US.",2020-12-13
F.D.A. Advisory Panel Gives Green Light to Pfizer Vaccine,"Pfizer’s Covid-19 vaccine passed a critical milestone on Thursday when a panel of experts formally recommended that the Food and Drug Administration authorize the vaccine. The agency is likely to do so within days, giving health care workers and nursing home residents first priority to begin receiving the first shots early next week.",2020-12-10
FDA panel recommends approval of Pfizer’s Covid vaccine for emergency use,"A key Food and Drug Administration advisory panel voted 17 to 4 with one member abstaining on Thursday to recommend the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use, the last step before the FDA gives the final OK to broadly distribute the first doses throughout the United States.",2020-12-10
Pfizer COVID-19 Vaccine Gets Approval from Key FDA Panel,An independent advisory committee for the Food and Drug Administration voted Thursday to recommendTrusted Source emergency approval of a COVID-19 vaccine developed by Pfizer and BioNTech.,2021-05-06
"U.K.'s Approval Of Pfizer Vaccine Should 'Give People Hope,' Vaccine Expert Says","The United Kingdom gave emergency approval this week to a COVID-19 vaccine and plans to begin rolling it out next week. Though Russia had previously approved a vaccine, the U.K. is the first country where regulators approved a vaccine that is backed by transparent science. The U.S. Food and Drug Administration will consider granting its regulatory approval next week.",2020-12-03
Covid vaccine: Pfizer applies for first approval in US,It will be the job of the US Food and Drug Administration (FDA) to decide if the vaccine is safe to roll out.,2020-11-20
FDA approves use of Pfizer COVID vaccine; shipments begin,"The Food and Drug Administration (FDA) last night announced it has issued an emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine, allowing shipments to begin and marking a significant milestone in the country's battle against the virus.",2020-12-12
Pfizer/BioNTech COVID-19 Vaccine Approved in the U.K.,"Vaccine hopes are starting to be fulfilled as the first COVID-19 vaccine gets authorized. U.K. regulators have approved the emergency use of Pfizer and BioNTech's mRNA vaccine after a ""thorough"" review and the government has accepted its recommendation. The country just lifted its second nationwide lockdown yesterday.",2020-12-02
Pfizer COVID-19 vaccine will go into use next week in the UK,"The UK has approved a COVID-19 vaccine and plans to implement the treatment as early as next week. British care home residents, older adults and health care workers will be first to be inoculated with the groundbreaking vaccine developed by Pfizer and BioNTech to tackle the coronavirus pandemic.",2020-12-02
Why the U.K. Approved a Coronavirus Vaccine First,"LONDON — The first rigorously tested coronavirus vaccine was given a green light for use on Wednesday in Britain. Doses of the vaccine, made by the American pharmaceutical giant Pfizer and a small German company, BioNTech, will be injected starting next week, the government said.",2020-12-02
FDA Panel Endorses Covid-19 Vaccine,"A Food and Drug Administration advisory panel recommended approving the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE, clearing the way for the agency to grant emergency authorization for the shot as early as Friday.",2020-12-11
FDA advisory panel endorses Pfizer/BioNTech Covid-19 vaccine,"A panel of outside experts on Thursday recommended the Food and Drug Administration issue an emergency use authorization to the Covid-19 vaccine being developed by Pfizer and BioNTech, a vaccine that appeared to be highly efficacious in a Phase 3 clinical trial.",20202-12-10
US panel endorses widespread use of Pfizer COVID-19 vaccine,"WASHINGTON (AP) — A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans.",2020-12-10
Head of FDA Advisory Panel Predicts Approval for Pfizer’s Covid-19 Vaccine,The leader of the advisory panel charged with evaluating the first Covid-19 vaccination to come before the U.S. Food and Drug Administration says the shot is very likely to obtain emergency-use authorization.,2020-12-09
FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine,"Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older.",2020-12-18
Two COVID-19 vaccines are now authorized in the US; here's what we know about them,"The Moderna vaccine began arriving across the nation Monday, just three days after it was authorized for emergency use by the Food and Drug Administration. It comes on the heels of the Pfizer-BioNTech vaccine, which is being given to health care workers and nursing home residents.",2020-12-21
Covid-19: F.D.A. Clears Pfizer Vaccine and Millions of Doses Will Be Shipped Right Away,The accelerated timeline comes after President Trump’s chief of staff threatened the F.D.A. head’s job if he didn’t get it done on Friday. The Trump Administration will buy another 100 million doses of Moderna vaccine.,2020-12-15
"Pfizer to nearly halve COVID-19 vaccine production timeline, sterile injectables VP says","With an upsized production goal of 2 billion COVID-19 vaccine doses this year, Pfizer and its German partner BioNTech aren’t resting on their laurels now that their shot, Comirnaty, has emergency nods in the U.S., Europe and beyond. As the companies continue to build out capacity, manufacturing efficiency is getting its own boost, Pfizer revealed.",2021-02-08
Pfizer hopes to cut vaccine manufacturing time by almost half,"By ramping up production and being more efficient, the company expects to reduce the time it takes to produce a batch of vaccine from 110 days to around 60.",2021-02-08
Pfizer Able to Cut Vaccine Production Time,"Pfizer expects to cut its COVID-19 vaccine production time by almost 50% as the process becomes more efficient, according to USA Today.",2021-02-08
Pfizer And Moderna To Dramatically Increase Covid-19 Vaccine Production This Spring,"Covid-19 vaccine distribution rates in the U.S. are likely to accelerate in the coming months to potentially twice the amount now being administered, as vaccine manufacturers project substantial boosts in production and the White House increases the number of doses it sends out to states.",2021-02-23
Drugmakers are ramping up Covid vaccine production after fixing initial manufacturing delays,"Drugmakers are significantly ramping up Covid-19 vaccine production after working out manufacturing issues that initially delayed the first shots, executives told Congress this week.",2021-02-24
Vaccine makers Pfizer and Moderna pledge massive boost to U.S. supply after sluggish rollout,"Drug companies told lawmakers Tuesday they project a major increase in vaccine deliveries that will result in 140 million more doses over the next five weeks, saying they have solved manufacturing challenges and are in a position to overcome scarcity that has hampered the nation’s fight against the coronavirus.",2021-02-23
"Pfizer, Moderna and J&J tout supercharged COVID-19 vaccine output, eyeing nearly 140M doses by March","Pfizer, Moderna and Johnson & Johnson execs say they're working all the angles on increasing COVID-19 vaccine production and expect to amp up weekly deliveries by tens of millions by the end of March",2021-02-23
"Pfizer expects to cut COVID-19 vaccine production time by close to 50% as production ramps up, efficiencies increase","Pfizer expects to nearly cut in half the amount of time it takes to produce a batch of COVID-19 vaccine from 110 days to an average of 60 as it makes the process more efficient and production is built out, the company told USA TODAY.",2021-02-07
Moderna Increases COVID-19 Vaccine Shipments While Pfizer Lags Behind,"President Biden said last Tuesday that his administration is already working on ordering more COVID-19 vaccine doses to increase the U.S. supply through this summer. But before that can happen, Pfizer and Moderna have to fulfill their commitments under their original federal supply contracts.",2021-02-01
Pfizer Could More Than Double Its Weekly COVID-19 Vaccine Production in March,Pfizer leadership announced Friday evening that their US coronavirus 2019 (COVID-19) vaccine output will more than double from the current count of 5 million doses weekly in the coming month.,2021-02-20
"Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ supply concerns","After a coronavirus vaccine supply feud between top officials in Europe and COVID-19 vaccine player AstraZeneca, officials there are doubling down on their purchase of an alternative technology. This week, the bloc finalized the purchase of 350 million additional mRNA vaccine doses.",2021-02-17
Report: Pfizer speeding up vaccine production,Pfizer (NYSE:PFE) is reportedly expecting to trim the time needed to produce COVID-19 vaccine batches to speed up production.,2021-02-10
BioNTech starts vaccine production at new site in Germany,Vaccine developer BioNTech has launched production of the COVID-19 vaccine it developed with US giant Pfizer at a new plant in the German town of Marburg. The facility could significantly boost the EU's vaccine supply.,2021-02-10
Pfizer's COVID-19 Vaccine 95% Effective in Final Phase 3 Results,"After initial promising interim results on November 9, Pfizer and BioNTech today announced that their mRNA vaccine, in development to prevent COVID-19, is 95% effective.",2020-11-18
Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis,"Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% effective. This is a better efficacy rate than Pfizer reported previously, when it announced a 90% effectiveness metric based on preliminary analysis of the Phase 3 trial data.",2020-11-18
"Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints","NEW YORK and MAINZ, GERMANY, November 18, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% (p<0.0001) in participants without prior SARS-CoV-2 infection (first primary objective) and also in participants with and without prior SARS-CoV-2 infection (second primary objective), in each case measured from 28 days after the first dose, 7 days after the second dose. The first primary objective analysis is based on 170 cases of COVID-19, as specified in the study protocol, of which 162 cases of COVID-19 were observed in the placebo group versus 8 cases in the BNT162b2 group. Efficacy was consistent across age, gender, race and ethnicity demographics. The observed efficacy in adults over 65 years of age was over 94%.",2020-11-18
Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial,"The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking infection in 90 percent of participants in its Phase 3 clinical trial, the companies announced on Monday. That’s based on data analyzed by an external, independent committee assigned to check the results of the trial, and reflects only early results from the trial, and not the final verified result — but it’s still extremely promising news for progress toward a viable and more broadly available vaccine.",2020-11-09
"Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate","Pfizer and partner BioNTech said Monday that their vaccine against Covid-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement — and relief — in the face of the global pandemic.",2020-11-09
"Pfizer, BioNTech say Covid vaccine is more than 90% effective — ‘great day for science and humanity’","Pfizer and BioNTech announced Monday their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, hailing the development as “a great day for science and humanity.”",2020-11-09
What Pfizer’s landmark COVID vaccine results mean for the pandemic,"New York City-based drug company Pfizer made the announcement on 9 November. It offers the first compelling evidence that a vaccine can prevent COVID-19 — and bodes well for other COVID-19 vaccines in development. But the information released at this early stage does not answer key questions that will determine whether the Pfizer vaccine, and others like it, can prevent the most severe cases or quell the coronavirus pandemic.",2020-11-09
Covid-19 vaccine efficacy results are not enough,"The recent results of Covid-19 vaccine clinical trials from teams at the University of Oxford and AstraZeneca, Moderna, and Pfizer and BioNTech have been some of the most exciting and promising developments in the pandemic to date.",2020-11-24
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine,"NEW YORK and MAINZ, GERMANY, December 10, 2020 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the New England Journal of Medicine has published safety and final efficacy results from the pivotal Phase 3 trial of BNT162b2, their mRNA-based COVID-19 vaccine candidate. In the trial of 43,448 participants, who were 16 years and older, 21,720 of whom received BNT162b2 and 21,728 placebo, the two-dose regimen of 30 mg BNT162b2, which was given 21 days apart, was well-tolerated and demonstrated vaccine efficacy of 95% against COVID-19.",2020-12-10
"Pfizer vaccine results are promising, but lack of data ‘very concerning,’ experts say","The world cheered this week after pharmaceutical companies Pfizer and BioNTech announced early findings from their phase three trial for a frontrunner COVID-19 vaccine. On November 9, the companies issued a news release claiming their vaccine candidate effectively prevented infection with the coronavirus—welcome news after soaring global cases have prompted new shutdowns and warnings of intensive care units filled to capacity.",2020-11-10